Stock-Based Compensation Plans - Summary of Stock Option Plan Comparison (Details) |
12 Months Ended |
|---|---|
|
Apr. 30, 2026
shares
| |
| Restated Option Plan | |
| Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Line Items] | |
| Minimum exercise price as a percentage of fair market value at date of grant | 100.00% |
| Last expiration date for outstanding options | May 09, 2034 |
| Shares available for grant at April 30, 2026 | 0 |
| 2024 Equity Incentive Plan | |
| Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Line Items] | |
| Minimum exercise price as a percentage of fair market value at date of grant | 100.00% |
| Last expiration date for outstanding options | Nov. 11, 2035 |
| Shares available for grant at April 30, 2026 | 281,790 |
| X | ||||||||||
- Definition Minimum exercise price of stock options as a percentage of fair market value at date of grant. No definition available.
|
| X | ||||||||||
- Definition Date the equity-based award expires, in YYYY-MM-DD format. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|